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ABSTRACT:  
 
The production of secondary neutrons is an undesirable byproduct of proton therapy. It is 
important to quantify the contribution from secondary neutrons to patient dose received 
outside the treatment volume. The purpose of this study is to investigate the off-axis dose 
equivalent from secondary neutrons using the Monte Carlo radiation transport code 
FLUKA. The study is done using a simplified version of the beam delivery system used 
at ProCure Proton Therapy Center, Oklahoma City, OK. In this study, a particular set of 
treatment parameters were set to study the dose equivalent outside the treatment volume 
inside a phantom and in air at various depths and angles with respect to the primary beam 
axis. Three different proton beams with maximum energies of 78 MeV, 162 MeV and 
226 MeV and 4 cm modulation width, a 5 cm diameter brass aperture, and a small snout 
located 38 cm from isocenter were used for the study. The FLUKA calculated secondary 
neutron dose equivalent to absorbed proton dose, Hn/Dp, decreased with distance from 
beam isocenter. The Hn/Dp ranged from 0.11 ± 0.01 mSv/Gy for a 78 MeV proton beam 
to 111.01 ± 1.99 mSv/Gy for a 226 MeV proton beam. Overall, Hn/Dp was observed to be 
higher in air than in the phantom, indicating the predominance of external neutrons 
produced in the nozzle rather than inside the body.  
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CHAPTER 1 
 
1 INTRODUCTION 
 
The objective of radiation therapy is to deliver a high dose of ionizing radiation to 
the treatment volume (cancerous tumor), while simultaneously minimizing the 
radiation dose to the surrounding healthy tissue. In radiation therapy, the use of a 
proton beam as ionizing radiation has been considering promising in the last decade 
primarily because energetic protons have a finite range and can be used to deliver 
maximum dose to the treatment volume. However, the advantage of proton 
radiotherapy can be compromised due to the effects of secondary neutrons. 
Secondary neutrons are an undesired byproduct of proton radiotherapy and the 
exposure of secondary neutrons outside the treatment volume can lead to 
secondary cancer later in the patient’s life. The aim of this work is to quantify the 
out of field dose equivalent due to secondary neutrons from uniform scanning beam 
delivery systems used in proton radiotherapy by means of simulations carried out 
using the Monte Carlo radiation transport code FLUKA.  
 
 
 2 
 
In proton radiotherapy, secondary neutrons are produced when the primary proton 
beam is guided and shaped via passage through different materials  inside the beam 
delivery system to conform the shape of the beam to the tumor (Zheng et al., 2007b, 
Mesoloras et al., 2006). Secondary neutrons are created mainly through non-elastic 
interactions of the primary protons of the treatment beam with atomic nuclei of the 
beam shaping materials (Perez-Andujar et al., 2009, Polf et al., 2005, Polf and 
Newhauser, 2005, Hecksel et al., 2010, Jiang et al., 2005, Zheng et al., 2007b, Zheng 
et al., 2008, Zheng et al., 2007a, Moyers et al., 2008, Binns and Hough, 1997). These 
secondary neutrons possess a wide range of energy, and sufficient range to reach 
deep into the patient’s body. Since neutrons have higher relative biological 
effectiveness (RBE) compared to protons or x-rays (Paganetti, 2007, Hall, 2006), 
they are capable of doing more biological damage to tissue.  
 
Exposure to secondary neutrons can increase the risk of secondary cancer later in a 
patient’s life. Although the risk associated with exposure to secondary neutrons is 
not completely understood, a recent study showed that the associated risk for a 15 
year male and female of developing a secondary cancer from secondary neutron 
exposure is about 20% and 44%, respectively (Brenner and Hall, 2008). Moreover, 
an understanding of the secondary radiation produced in proton radiotherapy is 
important for the optimization of dose delivery systems, shielding design, and 
overall quality of treatment. 
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The level of the secondary neutrons produced in proton radiotherapy depends on 
the design of the beam delivery system (Brenner et al., 2009, Tayama et al., 2006, 
Zheng et al., 2007a). Generally, there are two types of beam delivery system in 
proton radiotherapy: passive scattering and active scanning beam delivery systems. 
A detailed description of beam delivery system used in proton radiotherapy is given 
in section 2.5. Currently, both passive scattering and active scanning beam delivery 
systems are in use at different proton therapy centers, although passive scattering 
systems are used in the majority of facilities currently in operation (Koehler et al., 
1977, Arjomandy et al., 2009). In the passive scattering beam delivery system, the 
primary proton beam energy (and hence range) is varied by a range modulator 
(usually low-Z) and a second scatterer foil (usually of high-Z) is used to laterally 
spread the beam on to the target (Perez-Andujar et al., 2009). Active beam delivery 
systems, on the other hand, are of two categories: pencil beam scanning and 
uniform beam scanning systems. In pencil beam scanning systems, dose is deposited 
to the target volume with the help of variable proton energy and intensity, and the 
system may not require any beam shaping components. In uniform scanning 
systems, the system uses beam shaping components like a range modulator, patient 
aperture, and range compensator similar to that used in passive systems except that 
it uses magnets instead of scattering foils to spread the beam over the treatment 
volume. Overall, the uniform scanning system uses less material in the beam path 
than a passive scattering delivery system and thereby presumably produces fewer 
neutrons (Arjomandy et al., 2009).  
 
 4 
 
The uniform scanning beam delivery system in proton radiotherapy is a very recent 
development and few treatment centers currently use the uniform scanning method 
for patient treatment. The studies of secondary neutron dose due to uniform 
scanning are, therefore, scarce. The objective of this work was to quantify the dose 
equivalent due to secondary neutrons produced in the uniform scanning system 
inside the phantom patient and in air at different angles and locations relative to 
isocenter of the beam for different proton energies with a typical treatment set up. 
The study was carried out for the simplified version of the uniform beam delivery 
system used at ProCure Proton Therapy Center, Oklahoma City, OK.  
 
This work describes radiation therapy and the rationale for proton radiotherapy in 
Chapter Two. The different types of beam delivery system that are currently used in 
proton radiotherapy are also discussed here. Chapter Three discusses the 
fundamental dosimetric quantities required for the calculation of absorbed dose and 
dose equivalent. The fluence to dose equivalent conversion factor is a major concern 
in numerical simulation and this is discussed in Chapter Three. The simulation of 
the study and relevant parameters like the neutron cross section library, particle 
threshold, etc. used in FLUKA are described in Chapter Four. Chapter Five presents 
the results of the FLUKA simulations for secondary neutrons in proton radiotherapy 
for uniform scanning system at different angles and location from beam isocenter 
inside the phantom and in air. The dose equivalent is presented as the ratio of 
secondary dose equivalent due to neutrons to primary proton dose, Hn/Dp. Finally, 
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Chapter Six compares results from this study with published data for similar passive 
scattering and uniform scanning beam delivery systems.  
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CHAPTER 2 
 
2 PROTON RADIOTHERAPY 
 
 General Radiotherapy  2.1
 
The term radiation therapy or radiotherapy refers the use of ionizing radiation to 
kill or control tumor volume of cancer patients. The objective of radiotherapy is to 
deliver a high dose of ionizing radiation to a cancerous tumor in a noninvasive way, 
causing the cells of the tumor to die, while simultaneously minimizing the radiation 
dose to the healthy tissue surrounding the tumor. 
  
Radiotherapy is considered as one of the most effective treatments for cancer and 
more than half of all cancer patients receive radiotherapy at some point in their 
treatment (Tobias, 1996, Delaney et al., 2005). Surgery, the preferred choice of 
treatment, is successful for tumors in an early stage i.e. when the cancer does not 
metastasize or spread to other organs. Radiotherapy is considered a good 
alternative to surgery for long term control of tumors in the lung, cervix, bladder, 
prostate, head and neck, skin, and other organs. Chemotherapy, the third most 
important form of treatment, uses chemical agents, i.e. drugs, to control the 
cancerous cells (Joiner and Kogel, 2009). But the diseases for which chemotherapy 
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alone is considered effective are rare. Studies  suggest that radiotherapy along with 
surgery have a success rate of 40% for local treatments of most types of tumors 
(Souhami and Tobias, 1986, DeVita et al., 1979). Radiotherapy alone is suggested 
the principal form of treatment for about 15% of all types of cancers, whereas the 
cure rate due to chemotherapy is about 2% (Joiner and Kogel, 2009). Based on this 
study, it can be projected that the patient cure rate is around 7 times higher in 
radiotherapy compared to chemotherapy. However, depending on the stage of the 
cancer, radiotherapy is sometimes combined with chemotherapy or surgery for 
treating cancer patients. Generally, the precise treatment depends on the patient 
age, tumor location, stage of the tumor development and the general health of the 
patient.  
 
When ionizing radiation strikes the tumor, the DNA of the cells can become 
damaged either through direct or indirect interaction. DNA molecules are double-
stranded helices where the backbone is made of alternating sugar and phosphates; 
and the base pair consists of one of four nitrogen-containing biological compounds: 
guanine, thymine, cytosine, and adenine as shown in Figure 2.1 Cancer cells are 
generally less likely to repair the damage caused by direct or indirect action, 
compared to healthy cells, thus casing the cancer cells to reproduce more slowly or 
to die. An illustration of direct or indirect interaction is shown in Figure 2.2.  
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Figure 2.1:  A double helical DNA molecule. The four bases are Guanine, Thymine, Cytosine, 
Adenine. Picture was taken from (DNA, 2013).  
 
 
In direct interaction, ionizing radiation interacts directly with DNA of the cell. The 
damage to the cell occurs when ionizing radiation breaks one or both of the sugar 
phosphate backbones, the base pairs of the DNA, or some other cellular components 
essential for the survival of the cell.  
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Figure 2.2: A schematic representation of direct and indirect action. Picture was adapted 
from (Hall and Giaccia, 2006).  
 
Indirect reaction, on the other hand, occurs via free radical.  A free radical is a 
molecule, atom or ion that has an unpaired orbital electron in the outer shell. When 
ionizing radiation interacts with a water molecule, (major constituent of the cell), it 
creates a free radical,    
  (positively charged molecule and has an unpaired 
electron in the outer shell). This reaction can be expressed as 
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The ion radical interacts with another water molecule and forms a very reactive 
hydroxyl radical (   ), which can be shown as, 
  
   
         
       
 
The hydroxyl free radicals (   ) are extremely reactive and cause harmful 
chemical reactions within the cell. It has been shown that about two thirds of all 
damage done to cells are due to hydroxyl free radicals in indirect interactions (Saha, 
2006). Gamma and x-ray beam mostly damage the cell via indirect interactions, 
whereas energetic protons and carbons mostly damage the cell via direct 
interactions.     
 
 Types of Radiotherapy 2.1.1
  
Radiation therapy can be divided into two main groups: a) external beam radiation 
therapy (EBRT or XBRT), and b) internal radiotherapy. External beam radiation 
therapy uses an external source of radiation (outside the body) to treat cancerous 
tumors. X-rays and electrons are the most widely used form of radiation in external 
beam radiation therapy.  Generally, low energy (kilovoltage) x-rays and electrons 
are used for superficial tumors and skin cancers. Megavoltage x-rays are usually 
used for deep seated tumors such as tumors in the prostate, lungs, etc. Apart from x-
rays and electrons, protons and heavy ions are also used in external beam 
radiotherapy. External beam radiation therapy is further classified as conventional 
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and unconventional radiotherapy. Conventional radiotherapy includes x-ray and 
electron beam radiotherapy, while unconventional radiotherapy includes proton 
and heavy ion beam radiotherapy.  
Internal radiation therapy, on the other hand, places radioisotope inside or on the 
body (Patel and Arthur, 2006) to deliver dose to the treatment volume. This can use 
both sealed and unsealed radioactive sources (NCI, 2013). Brachytherapy is the 
method that uses sealed radioactive sources positioned in and around the tumor. In 
this method, radioactive sources are placed either interstitialy (source placed inside 
the tumor), intracavity (source placed inside a cavity), or on the surface (source 
attached to the surface) (Khan, 2003). The most common types of radioactive 
sources used in brachytherapy are 125I, 103Pd, 192Ir, 198Au. In this type of radiation 
therapy, a significant dose can be delivered locally to the tumor while a rapid dose 
fall off occurs adjacent in the normal tissues. This is commonly used for treating 
cancers such as prostate, cervical, breast, skin, etc. The unsealed source of 
radiotherapy uses soluble forms of radioactive sources such as 131I and is taken 
either via injection or ingestion. This is also called systematic radiotherapy (NCI, 
2013). This form of radiation therapy is effective for only some types of thyroid 
cancer as thyroid cells naturally absorb both radioactive and stable iodine (NCI, 
2013). However, depending on the tumor stage, a combination of external and 
internal beam therapy is sometimes prescribed.     
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 Rationale for using Proton Radiotherapy  2.2
 
Among different types of radiotherapy, the use of x-rays or electrons is the most 
common (99% of all forms of radiotherapy) (Sisterson, 2005), while proton and 
heavy ion radiotherapy makes up less than 1%. However, in conventional 
radiotherapy, the dose distribution to surrounding healthy tissue is significantly 
higher due to the greater scattering of x-rays or electrons inside the tissue than in 
proton or heavy ion radiotherapy.   
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Figure 2.3: Range of proton beam in water. Data taken from NIST website (NIST, 2012). 
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This problem is better handled by proton beams since protons are relatively heavy 
and have finite range in matter. The range of proton beam of therapeutic energy in 
water is shown in Figure 2.3 (NIST). A proton of a given kinetic energy has a finite, 
known range in water or tissue. Also, proton delivers maximum of its energy at the 
end of its range. Due to this property, protons deliver most of its energy at a certain 
range and the relatively large mass of proton leads to less scatter as they travel 
through the tissue. On the other hand, x-rays do not possess a finite range; rather 
they attenuate exponentially with depth in tissue. Due to these inherent properties, 
protons can be used to deliver a higher dose to the tumor while minimizing dose 
adjacent to the healthy tissue. X-rays, unlike protons, deliver its maximum dose near 
the entrance and the exponential dose fall off with depth causes a considerably 
higher dose to the healthy tissue.  
 
An example of dose deposition in tissue as a function of depth due to x-rays (20MV), 
electrons (4MeV), and protons (150 MeV) is shown in Figure 2.4. This figure shows 
that protons deliver most of their dose at the end of its range while the dose due to 
x-rays follows an exponential pattern. Electron beams show a greater dose fall off 
but clinically this advantage disappears as electrons do not possess great 
penetrating property. This leaves the use of electron beam radiotherapy effective 
mostly for shallow tumors.   
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Figure 2.4: Comparison of depth dose curve for x-rays (20MV), electrons (4MeV), and 
protons (150 MeV) beams. Picture taken from (Wikimedia, 2013). 
 
A clinical example  of dose distribution by x-ray and proton radiotherapy in a 
patient for the disease medulloblastoma is shown in the Figure 2.5 (Terezakis et al., 
2011). This figure shows that the dose distribution, (shown by the different shades 
of color) due to photon beam (top) is larger than that of proton beam (bottom). 
Clinically this advantage of precise dose distribution has led proton radiotherapy to 
be a superior modality compared to photon and electron radiotherapy (Dowdell, 
2011). For this reason, proton radiotherapy has been proving effective in critical 
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cases such as tumors in head and neck (Steneker et al., 2006, Dowdell, 2011), ocular 
tumors (Dendale et al., 2006), and tumors in pediatric patients (Dowdell).  
          
 
 
Figure 2.5: A comparison of dose distribution in a patient due to photon and proton 
beam for medulloblastoma (Terezakis et al., 2011).   
 
 Basics of Proton Therapy 2.3
 
The energetic protons of a proton radiotherapy beam interact with matter as they 
pass through it by three different mechanisms (Goitein, 2008): a) coulomb 
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interactions with atomic electrons, b) coulomb interactions with atomic nuclei, and 
c) nuclear interactions with atomic nuclei. Coulomb interactions with atomic 
electrons occur as the positively charged protons interact with negatively charged 
orbital electrons, transferring kinetic energy to the atomic electrons and producing 
ionization and excitation of the atoms. In ionization, the interacting protons transfer 
sufficient energy to knock out one or more electrons from the target atom. These 
secondary electrons can possess sufficient energy to cause further ionization in the 
region surrounding the initial interaction. Since protons are much heavier than 
electrons, the deflection of protons in this process is negligible. Protons also interact 
via coulomb fields of atomic nuclei as they penetrate through matter. Repulsion 
between incoming protons and atomic nuclei scatter protons, since nuclei are of 
equal or greater mass than the incident protons. However, after many such 
scattering events, the net statistical deflection is typically very small (Goitein, 2008).  
Nuclear interactions with atomic nuclei via the strong nuclear force is another 
process that leads to two types of collisions elastic collisions and non-elastic 
collisions. In elastic collisions, protons lose significant amounts of energy, but the 
target nucleus is left intact. In non-elastic collision, the incident protons penetrate 
the target nucleus and may cause the nucleus to break apart. As a result of non-
elastic nuclear collisions, fragments of the target nucleus may escape the region 
with a large momentum and may possess considerable kinetic energy. An example 
of such an interaction is shown in Table 2.1 for a 150 MeV protons on 16O (Seltzer, 
1993).  
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Table 2.1: Energy taken up by various particles as a result of 150 MeV protons 
incident on 16O nucleus (Seltzer, 1993).  
Particle Fraction of energy (%) 
Protons 57 
Neutrons 20 
Alpha particles 2.9 
Deuterons 1.6 
Tritium 0.2 
Helium-3 0.2 
Recoil fragments 1.6 
 
 
The primary mechanism for energy loss by protons passing through matter is due to 
Coulomb interactions with atomic electrons in the medium. The loss of energy due 
to Coulomb interactions can be calculated using the Bethe-Bloch formula (Bethe, 
1930):   
  
  
  
 
   
 
    
    
   2.1 
where  
  
  
 is the energy lost by the incident charged particle proton per unit path 
length, ne represents the electron density of the target, e represents electron charge, 
 represents the permittivity of free space, m is the rest mass of the electron, L 
represents a collection of logarithmic factors and correction factors and is given by: 
     (
    
 
)    (  
  
  
)  
  
  
 
 
 
  2.2 
The standard relativistic corrections,           ⁄        ⁄  are important if the 
projectile in the interaction is moving at a significant fraction of the speed of light. If 
the velocity of the projectile is small compared to the speed of light, equation (2.2) 
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simplifies to L         ⁄    where   is the velocity of the incident charged particle 
and I is the mean ionization potential. The term,   ⁄ , in equation (2.2) represents 
the density effect correction (Sternheimer and Peierls, 1971).  
 
The energy lost by the incident proton is roughly proportional to the inverse square 
of its velocity and, therefore, as the proton slows down, the rate of energy 
deposition increases. The greatest loss of energy occurs at the end of the proton 
range and this causes a peak at the end of the range which is called the Bragg peak. 
An example of a Bragg peak for a 200 MeV proton in water is shown in Figure 2.6 
(Jones and Schreuder, 2001). The width of the peak is caused by a phenomenon 
called range straggling, which occurs due to the statistical variations in the 
ionization processes. In other words, not all the protons will stop at the same range 
as there are statistical differences in ionization processes and this spreads out the 
depth at which the proton beam stops. In addition, the energy of the incident proton 
beam is never completely monoenergetic and this also leads to spreading out of the 
Bragg peak.  
 19 
 
 
Figure 2.6: A Bragg peak for 200 MeV proton beam in water (Jones and Schreuder, 2001) . 
 
 Spread out Bragg peak 2.4
 
Usually, the width of the Bragg peak of a proton beam is not wide enough to 
completely cover a tumor. Therefore, the Bragg peak needs to be spread out in 
depth to completely cover the whole tumor volume. The enlargement of the peak 
dose region of Bragg peak is known as spread out Bragg peak (SOBP) in proton 
radiotherapy.   
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Figure 2.7: A common range modulator wheel used in proton radiotherapy. Picture taken 
from (Schlegel et al., 2006). 
 
Multiple Bragg peaks are combined together to enlarge the peak to deliver uniform 
dose to the treatment volume. The desired SOBP is achieved by running the proton 
beam through an appropriate range modulator. A modulator wheel consists of 
absorbers of variable thicknesses on a circular disk as shown in Figure 2.7. A 
combination of low-Z (lexan or carbon) and high-Z (lead) material  is used in a 
modulator wheel (Schlegel et al., 2006). The low-Z material is used to slow down the 
beam with little scattering, whereas the high-Z material is used to adjust the 
scattering at each depth. Each absorber thickness of the range modulator, 
contributes to an individual Bragg peak and the increasing widths of the absorber 
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leads to Bragg peaks of decreasing depths as shown in Figure 2.8. Each Bragg peak is 
assigned with a weight factor and a series of such Bragg peaks is finally weighted to 
create the desired SOBP (Schlegel et al., 2006). An example of weighted SOBP for 
maximum energy of 200 MeV proton beam, composed of different Bragg peaks using 
a range modulator, is shown in Figure 2.8. 
 
 
Figure 2.8: Illustration of the SOBP production using a range modulator for the maximum 
200 MeV proton energy (ICRU, 2007). 
 
As shown in the figure, at each step of the range modulator, each Bragg peak 
corresponds to a particular depth and weight. The total SOBP is finally created by 
combining the individual Bragg peaks according to their respective weights.  
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 Beam Delivery Techniques 2.5
 
In order to conform the dose distribution to the tumor, the proton beam must be 
correctly shaped both laterally and longitudinally by the beam delivery system 
before it is applied to the patient. Currently, there are two types of beam delivery 
systems available: passive scattering and active scanning. In proton radiotherapy, 
active scanning method is considered to have the following advantages over passive 
scattering method (Albertini, 2011): a) it may not require a patient aperture or 
range compensator to achieve dose conformity, thereby minimizing exposure to 
secondary radiation, b) it requires less protons than passive scattering to achieve a 
total dose in a given volume, so less dose is delivered to the normal tissue, and c) it 
is considered to be more flexible in clinical use.  
 
 Passive Scattering 2.5.1
 
Passive scattering method is the most common beam delivery system used in proton 
radiotherapy (Zheng et al., 2007a). Passive scattering systems may use either a 
single scattering method or a double scattering method to treat the patient. In the 
single scattering method, a single piece of high-Z material (lead) is used to spread 
the beam laterally, whereas in double scattering technique a second scatterer is 
used further downstream to scatter the central part of the beam as shown in Figure 
2.9. The second scatterer may consist of bi-material scatterers: a combination of low 
and high-Z materials. In the single scattering method, only 10% of the beam remains 
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within the central uniform region, making the single scattering method efficient only 
for small field size. For larger field size, efficiency is improved by the double 
scattering method, where up to 45% of the beam remains within the central region 
(Gottschalk, 2004).  If a small field is required for delivering dose, single scattering 
method is preferred and for relatively larger fields, double scattering method is 
preferred (Goitein, 2008).  Both types of scattering methods are currently in use in 
proton radiotherapy. 
 
 
Figure 2.9: Schematic diagram of passive scattering system for proton radiotherapy.   
 
As shown in Figure 2.9, when the beam enters the delivery system, it passes through 
the first scatterer, the range modulator wheel, the second scatterer, ionization 
chambers and finally the patient aperture and range compensator. The first and 
second scatterers spread out the beam laterally, while the range modulator spreads 
the beam in depth. The ionization chambers monitor the beam flatness, symmetry 
as well as the amount of delivered dose. Finally, the aperture and the range 
compensator conforms the proton beam to the treatment volume. 
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The aperture and range compensator is placed in a removable device called a snout 
(Figure 2.9). The snout is attached at the end of a fixed beam delivery system. 
Depending on the treatment field size, various types of snouts are available in 
proton radiotherapy. For example, the ProCure proton treatment center, Oklahoma 
City, OK, currently employs three snouts: snout10, snout18, and snout25 (Zheng et 
al., 2012). The number of each snout corresponds to the diameter of the maximum 
field size attainable using that snout, i.e. snout10, snout18, and snout25 corresponds 
to a maximum ﬁeld size of 10, 18, and 25 cm diameter circular ﬁeld, respectively.  
 
The aperture shapes the treatment field to a desired target profile. This is a custom 
made patient specific tool designed according to the shape of the treatment volume. 
Generally, apertures are made of brass. The distal part of the dose deposition is 
shaped using patient specific range compensator. Usually, range compensator is 
made out of plastic to adjust the range of the protons to the distal end of the 
treatment volume.   A custom patient aperture and a range compensator is shown in 
Figure 2.10. The combination of patient aperture and range compensator is used to 
shape the beam according to the patient treatment volume.  
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Figure 2.10: A custom patient aperture (left), and a custom made range compensator 
(right). Picture taken from (Decimal, 2013). 
 
 
 Active Scanning Technique  2.5.2
 
An alternative to the passive scattering method is active scanning. This was first 
suggested by Kanai et al. (Kanai et al., 1980) and has subsequently been 
implemented at different facilities around the world (Albertini, 2011). Active 
scanning system uses magnetic fields to deflect the proton beam over the treatment 
volume (Albertini, 2011). Scanning magnets are used for the necessary magnetic 
field required to scan the beam in the x-y plane perpendicular to the beam direction 
(Farr et al., 2008). The scanning in depth (z direction) to the treatment volume is 
done by means of energy variation. Combining the scanning ability and energy 
range 
compensator 
patient 
aperture 
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variation, the Bragg peak can then be effectively placed anywhere inside the tumor 
volume.  
 
Active scanning systems are classified into two categories (Zheng et al., 2012): a) 
pencil beam scanning, and b) uniform scanning. The basic differences in pencil beam 
scanning and uniform scanning are the following: 1) pencil beam scanning employs 
beam of variable intensity during scanning while uniform scanning employs a beam 
of uniform intensity, 2) pencil beam scanning generally does not require any patient 
specific aperture (Goitein, 2008) such as collimator and range compensator, while 
uniform scanning system uses patient specific aperture and range compensator.  
 
 Pencil beam scanning 2.5.2.1
 
In pencil beam scanning, a pencil beam (few mm narrow) of variable intensity is 
used to scan different planes (layers) of the treatment volume using sweeping 
magnets. The irradiation as a function of depth is done by means of changing beam 
energy. A schematic diagram of a pencil beam scanning system is shown in Figure 
2.11. In this method, the beam starts by irradiating the deepest layer of the target 
and is scanned over that layer. The energy is then reduced such that the beam stops 
in relatively shallower layer and is then scanned over that layer. This process 
continues until the proximal end of the target is covered.  
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Figure 2.11: Schematic diagram of spot scanning delivery system in proton radiotherapy.  
 
The scanning part can be done primarily in two different modes: spot scanning and 
raster scanning or continuous beam scanning (Schlegel et al., 2006). In spot 
scanning, the dose is delivered to a given spot of a particular layer of the target in a 
predetermined pattern at constant magnetic settings (Kanai et al., 1980). The beam 
is then turned off and magnetic settings are changed to irradiate the next spot. The 
process continues until all the predetermined spots of all layers are covered.  The 
raster scanning or continuous beam scanning is very similar to spot scanning 
method except that the beam is not turned off while moves to the next spot of the 
target.    
 
 Uniform scanning  2.5.2.2
 
In a uniform scanning system, a beam of uniform intensity is scanned over different 
layers of the treatment volume. A schematic diagram of a uniform scanning IBA 
system (Louvian-la-neuve, Belgium) is shown in Figure 2.12. When the proton beam 
enters the beam delivery system, it passes through a first scatterer, a range 
 28 
 
modulator wheel, the magnetic fields of the scanning magnets, ionization chamber 
and finally the patient aperture and range compensator. The first scatterer enlarges 
the beam spot and the combination of first scatterer and range modulator wheel 
lowers the beam energy according to the need. The modulator wheel rotates from 
layer to layer and allows the beam to penetrate to a particular depth of a tumor. The 
sweeping magnets deflect the beam by sweeping back and forth, creating a pattern 
of uniform intensity (Zheng et al., 2012).  The ionization chambers monitor the 
beam uniformity, symmetry as well as the amount of delivered dose. Finally, the 
beam passes through a patient aperture and a range compensator contained in a 
snout. The combination of patient aperture and range compensator conforms the 
beam to the tumor shape and adjusts the proton range to the distal end of the 
tumor.  Like pencil beam scanning, the uniform scanning system irradiates the 
target volume with the most distal layer of the target, then moves on to the next 
shallower layer. The process continues until the proximal edge of the target is 
covered.  
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Figure 2.12: Schematic diagram of IBA uniform scanning nozzle. The components in the 
nozzle is not in scale.   
 
The study reported on in this work determined the dose equivalent from secondary 
neutrons produced by a uniform scanning system. It is important to note that 
uniform scanning devices use similar beam shaping components (aperture and 
range compensator) as used in passive scattering systems. The difference is that no 
second scatterer is used in uniform scanning systems.     
 
 Secondary Neutron Production 2.6
 
In proton radiotherapy, the primary proton beam is shaped using different beam 
shaping devices: scatterer, range modulator, patient collimator and range 
compensator. The interaction of the proton beam with these devices is likely to 
produce secondary particles through non-elastic nuclear interactions (Brenner et 
al., 2009). The production of secondary particles depends on the type of material 
and the energy of the incident protons. These secondaries may consist of different 
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types of particles including neutrons, electrons and alpha particles. Of these 
secondary particles, neutrons are the most potentially damaging as they possess a 
high relative biological effectiveness (RBE). Exposure to secondary neutrons of 
healthy tissue outside the target volume may lead to a secondary cancer  later in the 
life of the patient (Hall and Giaccia, 2006). Apart from the beam shaping material, 
the patient’s body itself can generate a fair number of secondary neutrons (Dowdell, 
2011). Since these neutrons are created inside the patient, some exposure of healthy 
tissue to secondary neutrons is unavoidable. 
 
The level of secondary neutron production depends largely on the beam delivery 
system since each beam delivery system uses different beam shaping components. 
Among them, the patient specific aperture is considered to be the dominant 
contributor of secondary neutrons to patient dose received otside the treatment 
volume (Jiang et al 2005, Mesoloras et al 2006, Zheng et al 2007, Zacharatou 
Jarlskog et al 2008, Perez-Andujar et al 2009). It is important to note that, in all 
cases, the field size is larger than the patient specific aperture (Brenner et al., 2009). 
This is due to the limited number of field sizes the accelerator can produce. This 
overlap in field size and aperture, along with the continual scanning of the beam 
until the prescribed dose to the treatment volume is met, will produce secondary 
neutrons.  
 
The neutrons produced by protons in the energy range of 65 to 250 MeV are the 
result of two nuclear processes: a) intranuclear cascade, and b) nuclear evaporation. 
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A graphical illustration of the intranuclear cascade process and evaporation process 
is shown in Figure 2.13. The intranuclear cascade process is particularly important 
for proton energies greater than 50 MeV (Benton, 2004). The process takes place 
when incident particles interact with the nucleons of a target nucleus and produce 
protons, neutrons, alpha particles and occasionally heavier nuclei at lower energy 
but at wider angles (Figure 2.13). The emission of these particles during an 
intranuclear cascade occurs usually in the forward direction, i.e. in the direction of 
the primary beam. The particles emitted due to intranuclear process can undergo 
additional nuclear interactions which are called extra nuclear cascades. The 
probability of an extra nuclear cascade in proton radiotherapy is small as the energy 
required for such events is greater than a few hundred MeV. The neutrons produced 
due to intranuclear cascades start from about ~10 MeV and can be as high as the 
incident proton energy (Zheng et al., 2007a).  
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Figure 2.13: Illustration of intranuclear cascade and evaporation process.  
 
The evaporation process, on the other hand, occurs in a multi-step processes. After 
the initial collision by an incident proton and a following intranuclear cascade, the 
target nucleus is often left in an excited and unstable state (Figure 2.13), commonly 
referred as compound nucleus (Benton, 2004). The nucleus can de-excite and 
achieve stability through the evaporation of neutrons, protons, and alpha particles. 
The emission of these particles by the evaporation process is nearly isotropic. 
Neutrons emitted as a result of evaporation process range in energy from 0 to 
10 MeV (Zheng et al., 2007a).  
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 Secondary neutron interaction with matter   2.7
 
A neutron can interact in a number of ways with a nucleus. The probability of such 
an interaction is expressed in terms of cross section (Rinard, 1991), having 
dimensions of area, i.e. cm2. In nuclear physics, cross section is often given in units 
of barns (1 barn equals to 10- 24 cm2). Depending on the energy of the neutron and 
the type of target nucleus, various types of interactions (Figure 2.14) are possible. 
The total cross section represents the probability of any such interactions.  
 
 
Figure 2.14: Different types of neutron interaction.    
 
Generally, two major types of neutron interaction are possible with matter: a) 
scattering, and b) absorption. In scattering interaction, a neutron is scattered by a 
target nucleus where the direction and speed of the incident neutron changes, but 
the target nucleus is left intact. Scattering events are further divided into two 
categories: elastic, and inelastic scattering. In elastic scattering, the total kinetic 
energy of the event is conserved and the internal state of the target nucleus and 
neutron remains unchanged. In inelastic scattering, the total kinetic energy is not 
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conserved because the target nucleus undergoes some internal arrangement that 
eventually leads to the emission of radiation (Rinard, 1991).  
     
In the absorption process, a neutron is absorbed by the target nucleus. As shown in 
Figure 2.14, due to the absorption, a wide range of emission may occur or fission 
may be induced.  When a neutron is absorbed by a target nucleus: a) the target 
nucleus may move to higher excited state and the de-excitation may lead to the 
emission of electromagnetic radiation i.e. gamma rays, b) emission of charged 
particles like protons, deuterons and alpha particles may take place, c) neutral 
particles (neutrons) may be emitted, and d) a fission event, i.e. the nucleus to splits 
into two or more fragments and a number of neutrons may occur (Rinard, 1991).  
 
Total cross section of a neutron depends on its incident energy. Neutrons are 
classified into four groups based on their energy: fast neutrons (> 500 keV), 
intermediate neutrons (10 keV-500 keV), epithermal neutrons (0.5 eV-10 keV), and 
thermal or slow neutrons (< 0.5 eV).  Fast and intermediate neutrons, in general, 
undergo scattering interaction while thermal or epithermal neutrons undergo 
absorption interaction.  
 
 
 Total cross section of secondary neutrons on tissue   2.8
 
The total cross section of neutrons on tissue largely depends on the interaction of 
neutron with hydrogen, carbon, and oxygen since they are the most common 
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elements in human body. Fast neutrons (> 1 MeV)  interact with carbon and oxygen 
nuclei in tissue through inelastic process and can release alpha particles (Figure 
2.15) (Hall and Giaccia, 2006). These alpha particles deposit dose to the tissue. 
Intermediate energy neutrons (10 keV-500 keV) transfer energy to the tissue via 
elastic scattering with the nuclei (protons) of hydrogen atoms. In this process, an 
incident neutron elastically scatters off by hydrogen nucleus transferring energy 
and creating a recoil proton (Figure 2.16). Thermal neutrons (< 0.5 eV) transfers 
energy through absorption process.  
 
 
 
Figure 2.15:  A schematic representation of neutron interaction with carbon (top), and 
oxygen (bottom) nucleus, results three and four alpha particles respectively. Picture taken 
from (Hall and Giaccia, 2006).  
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Among different interactions, neutron interaction with hydrogen nuclei via elastic 
scattering is considered the dominant mechanism of energy transfer to soft tissue 
(Howell, 2010). The reasons for this are: a) hydrogen is the most abundant element 
in tissue, b) the similar mass of a proton and a neutron allows maximum energy to 
be transferred in elastic scattering, and c) hydrogen possesses a large elastic 
scattering cross section for neutrons (Hall and Giaccia, 2006).  
 
 
Figure 2.16: A schematic representation of fast neutron’s interaction with hydrogen 
atom inside tissue (Hall and Giaccia, 2006).    
 
Total cross sections for incident neutrons (energy up to 20 MeV) on hydrogen, 
carbon and oxygen are shown in Figure 2.17 (NNDC, 2013). This figure shows that 
the total cross sections for neutrons on carbon, hydrogen and oxygen are either 
decreasing or constant with energy due to inelastic and elastic interactions, 
respectively. The resonance peaks (around 0.1 to 10 MeV) are present for carbon 
and oxygen but not for hydrogen.  
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Figure 2.17: The average total cross section of neutron for carbon, oxygen and hydrogen as 
a function of incident neutron energy (NNDC).  
 
Figure 2.17 shows that the average total cross section for hydrogen is about an 
order of magnitude greater than that of carbon and oxygen, for the identical neutron 
energy. The hydrogen content in tissue, therefore, dominates the neutron response. 
For this reason and because of the similarity of the atomic mass percentage (Table 
2.2) of hydrogen in both, water and tissue (ICRU muscle), this study considers water 
for the study of neutron response on tissue. Also in radiation therapy, water is 
considered to be a standard replacement of tissue for beam commissioning, 
machine calibration, or patient dose verification (Das et al., 2008). 
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Table 2.2: Atomic percentages for ICRU muscle (Collums, 2012) and water. 
Content Atomic percentages (%) 
ICRU muscle water 
H 63.3 66.67 
C 6.4  
O 28.5 33.33 
other 1.8  
 
The total cross section as a function of neutron energy on water and ICRU muscle is 
shown Figure 2.18. The negligible difference of neutron average total cross section 
on water and tissue (ICRU muscle) demonstrate that the water is a reasonable 
replacement of tissue for neutron study.   
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Figure 2.18: The average total cross section of neutron for ICRU muscle and water as a 
function of incident neutron energy(NNDC, 2013).  ICRU muscle cross section is multiplied 
by 10 in the graph for clarity . 
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CHAPTER 3 
 
3 DOSIMETRIC QUANTITIES 
 
This chapter describes the dosimetric quantities including particle fluence, LET 
(linear energy transfer), dose and dose equivalent. The fluence to dose conversion 
coefficients used in FLUKA is described. A standard guideline for radiation leakage 
in radiation therapy is also mentioned.       
   
 Particle Fluence 3.1
 
According to the international commission of radiation units and measurements 
(ICRU), particle fluence,  , is defined as the number of particles,   , that cross a 
unit area,    (ICRU, 1998a): 
   
  
  
  (3.1)  
The SI unit of particle fluence is particles/m2. For isotropic or nearly isotropic 
situations, fluence is corrected for solid angle,   
   
  
    
  (3.2)  
where the unit is cm-2sr-1. 
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 Linear Energy Transfer (LET) 3.2
 
Linear energy transfer (LET) is the energy deposited per unit path length when a 
particle passes through a medium.  LET depends on both the type of radiation and 
the target material. LET is determined by the rate of energy loss in the medium:  
     
  
  
 (3.3) 
where dE denotes the energy loss in the length, dl, of the stopping medium. The SI 
unit for LET is Joules/meter, though in radiation dosimetry LET is commonly 
expressed in keV/m.  
LET is related to quantities like mass stopping power and linear stopping power. 
The mass stopping power is similar to linear stopping power except that it is 
independent of density of the material. According to the ICRU (ICRU, 1998b), the 
mass stopping power,  
 
 
 is  
 
 
 
 
 
 
  
  
  (3.4) 
where, S, is linear stopping power and   is the density of the material.  The SI unit of 
mass stopping power is J.m2/kg but in practice mass stopping power is usually 
expressed as MeV·cm2/g. The linear stopping power primarily accounts for the 
energy loss due to atomic collisions (electronic loss) and can be estimated using the 
Bethe-Bloch formula.  
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 Absorbed dose and dose equivalent  3.3
 
Absorbed dose refers to the amount of energy absorbed per unit mass of material as 
a result of radiation exposure and can be expressed as:  
   
  
  
   (3.5)  
where, dE is the energy absorbed in the mass, dm, of the material. The SI unit of the 
absorbed dose is the Gray (Joule/Kg). The absorbed dose can be calculated as: 
   
          
 
       
(3.6) 
  
where   is he fluence and   is the density of the material and the factor       
     converts the keV to joules. Equation (3.6) represents dose for a monoenergetic 
beam, i.e. all particles possess one fixed LET. For a mixed field, the LET of each type 
of radiation and energy needs to be considered: 
   
          
 
∑       
 
  (3.7)  
where, the subscript “n” accounts the type of the radiation and energy, and    and 
     are the corresponding fluence and LET, respectively.  
 
Dose equivalent estimates the biological damage due to the absorbed dose in 
matter. The International Commission on Radiological Protection (ICRP) defines 
dose equivalent as the product of the absorbed dose and LET dependent quality 
factor, Q (LET): 
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           . (3.8)  
The SI unit of dose equivalent is the Sievert. The quality factor, Q, has been adopted 
from annex A of ICRP Publication No. 60 (ICRP, 1991) as shown below: 
        {
    
            
    √    
 
             
                        
               
 
(3.9) 
  
A plot of Q value against LET is shown Figure 3.1.  
 
Figure 3.1: Quality factor, Q, as a function of LET as defined in ICRP Publication No. 60 
(ICRP, 1991). 
 
It is important to mention that the quality factor is determined based on stochastic 
endpoints rather than deterministic endpoints. In stochastic processes there is no 
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threshold for biological damage including the induction of cancer, whereas, in 
deterministic processes, a biological threshold is considered.  
 
This process of determination of the absorbed dose and dose equivalent is LET 
dependent. However, in 1991, ICRP-60 (ICRP, 1991), introduced few new quantities 
to replace the LET dependent dose equivalent. The first of these quantities is the 
equivalent dose, HT: 
    ∑       
 
 (3.10)  
where   is the radiation weighting factor and depends on the energy and type of 
the incident radiation and     is the absorbed dose average over the specific tissue 
or organ, T, by the radiation, R. The ICRP-60 defined weighting factors are shown in 
the Table 3.1. 
Table 3.1: Radiation weighting factor, wR, as defined in ICRP-60 (ICRP, 1991) 
for neutron of different energy range.   
Energy                                                                        
<10 keV                                                             5 
10 keV to 100 keV                                           10 
>100 keV                                                          20 
2MeV to 20 MeV                                              10 
>20 MeV                                                            5 
 
The second quantity is the effective dose, E:  
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   ∑      
 
 (3.11)  
where   is the weighting factor for the tissue, T, and   is the equivalent dose.  The 
effective dose represents the sum of the weighted equivalent doses in all tissues and 
organs of the human body. The weighting factor    is available at ICRP-60.  
 
FLUKA calculates dose equivalent using fluence to dose equivalent conversion 
coefficients. The coefficients are determined based on radiation weighting factor, 
    and are described at ICRP publication No 74 (ICRP, 1996). A spline fits to the 
conversion coefficients of ICRP publication No 74 (ICRP, 1996) was employed in the 
code. Also a separate conversion coefficients was calculated by Pelliccioni 
(Pelliccion, 1998) and implemented in the FLUKA code for higher energy of 
neutrons (Roesler and Stevenson, 2006). The fluence to dose equivalent conversion 
coefficients for ICRP74, Pelliccioni and the fitted curve (AMB74) is shown in the 
Figure 3.2. FLUKA employs the fitted curve AMB74 (shown by red line) and the 
coefficients determined by Pelliccioni (shown by blue diamond) in the dose 
equivalent calculation.  
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Figure 3.2: Ambient dose equivalent coefficients as a function of neutron energy. 
Plot taken from (Roesler and Stevenson, 2006). 
 
 Guidelines to leakage Radiation Exposure 3.4
 
Currently, there are no active regulations or guidelines for the radiation leakage 
from proton or heavy ion therapy unit (Moyers et al., 2008). However, different 
states in the USA have their own states regulations for radiation therapy. Most 
therapy facility still follows the recommendations made by the American 
Association of Physicists in Medicine (AAPM) task group for electron and x-ray 
therapy. In 2006, the International Electro-Technical Commission (IEC) 
recommended that the physical dose due to leakage of primary particles 
downstream of beam line should be within 2% of prescribed dose (Moyers et al., 
2008). But no recommended dose for neutrons was mentioned. It should be noted 
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that neutron energy and fluence vary from proton radiotherapy center to center and 
depends on the beam delivery technique. Also, the existing literature (Moyers et al., 
2008) supports the view that the published data on secondary neutrons in proton 
radiotherapy is not adequate for making any conclusive recommendation on 
neutron exposure. However, since neutrons possess a higher RBE  and the neutron 
exposure could lead to secondary cancer later in the patient’s life, the absorbed dose 
from neutrons should be as low as possible (Hall, 2006).  
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CHAPTER 4 
 
4       FLUKA SIMULATIONS 
 
 Monte Carlo Code FLUKA 4.1
 
The term Monte Carlo refers to the repeated random sampling technique, where a 
physical event is simulated by observing the probable behavior of that system from 
the outcome of a large number of trials. Each of the trial is played on a computer by 
a sequence of random numbers. With the help of random numbers, this method 
simulates a physical problem via probabilistic approach. Therefore, this is 
sometimes called a virtual experiment. 
 
 An illustration of the Monte Carlo method in the radiation transport is shown in 
Figure 4.1 for an isotropic monoenergetic neutron source placed inside a shielding 
sphere. The trajectory of each neutron inside the shield is shown by succession of 
straight lines whose lengths and directions are random relative to each other. Monte 
Carlo method predicts this trajectory based on the probability of neutron’s 
interaction probability (cross section) with the shielding material. For instance, in 
the first step of the history, the free-path length (the path without interactions) of a 
neutron is determined by using a random number following the technique, 
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mathematical transformation. The second step is decided based on the first step i.e. 
in the first step if the neutron is scattered, or absorbed. If it is absorbed the history 
ends and if it is not absorbed the history continues until it is absorbed. The outcome 
of such events demonstrates how many neutrons may escape from the shielding. 
For example, if N is the total number of neutron history generated and n of that 
escapes then the probability of a neutron that escape from shielding is n/N. The 
statistical uncertainty of any such event is related to the number of total number of 
history generated in the process. The more the history generated the better the 
statistical uncertainty will be.              
 
 
Figure 4.1: Illustration of Monte Carlo approach using an isotropic neutron source. Picture 
taken from (Hendricks, 1994).  
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This study uses Monte Carlo radiation transport code called FLUKA to study the 
neutron dose equivalent from uniform scanning proton beam. FLUKA is an 
integrated Monte Carlo simulation package which is widely used in many areas of 
physics, engineering including high energy experimental physics, medical physics, 
cosmic ray research, radiation detector design, radiation shielding design of 
radiotherapy units etc. (Andersen et al., 2004, Aiginger et al., 2005, Ballarini et al., 
2007, Battistoni et al., 2007, Fassò et al., 2005).  
 
FLUKA was originally developed by the European Organization for Nuclear 
Research (CERN) to model the secondary radiation environment produce by particle 
accelerators. Later the code was adapted for the predictions of dosimetric quantities 
in medical physics and in radiobiology. FLUKA can reproduce the interactions and 
propagation of about 60 different particles in matter with excellent accuracy. This 
code can track electrons and photons from 1 keV to thousands of TeV, hadrons of up 
to 20 TeV and all the corresponding anti particles including neutrons down to 
thermal energy. This code can also simulate polarized photons (e.g. synchrotron 
radiation) and optical photons. FLUKA can also track emitted radiation from 
unstable residual nuclei and their corresponding time of evolution. The code is 
developed in such a way that it can correctly model the behavior of charged 
particles in the presence of magnetic and electric fields.  
 
In this study, we used FLUKA to simulate all the relevant physics that occurs when a 
proton beam penetrates into and passes through the complex mass distribution 
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represented by the beam delivery system and a phantom patient. Individual primary 
protons are treated through the geometrical mass distribution and at each point 
along proton’s trajectory, the probability of different electronic and nuclear 
interactions is calculated and an outcome of that interaction is determined based on 
a weighted random number. The products of these interactions including neutrons 
are in turn followed through the mass distribution and the probability of 
interactions of these secondary particles with the mass is in turn calculated. This 
continues until all the particles produced as a result of the incident primary proton 
either stop or leave the volume of interest (i.e. enter the black hole). This calculation 
is repeated for a large number of primary protons so as to obtain convergence on an 
average with good statistics. Finally, the LET spectrum, dose, and dose equivalent 
are scored by adding up the outcomes of all the simulations at particular locations of 
interest within the volume of interest.         
 
There are three main components in FLUKA structure: a) geometry of the problem, 
b) physics set up, and c) scoring. In the geometry section, the combinatorial 
geometry principle is used. For example, basic bodies, such as cylinders, spheres, 
parallelepipeds, etc. are combined to build a complex region of the problem. The 
combination is performed using basic Boolean operations- union, intersections and 
subtractions. Each region of the geometry is assigned with an appropriate material. 
After the geometry is built, it is mandatory to surround the geometry using a region 
called the “black hole”. The purpose of the black hole is to stop infinite tracking of 
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particles, i.e. particles need to be stopped at some point. The black hole stops those 
particles which are no longer in the user’s region of interest.   
 
In the physics component, FLUKA employs appropriate physics to simulate particle 
interactions including hadron inelastic nuclear interactions, elastic scattering, 
nucleus-nucleus interactions, etc. FLUKA also has the capacity of transporting 
particles of particular range of energy. The transport of all FLUKA particles can be 
enabled for energies as low as 1 keV. Neutrons can be transported to energies as low as 
10
-5
 eV. Secondary electron production threshold (minimum energy required to produce a 
secondary electron) can be as low as 1 keV for all particles and 10
-5
 eV for neutrons. A 
detailed description of physics and the related data which has been employed in 
FLUKA can be found at (FLUKA, 2013).                  
 
In scoring section, FLUKA estimates or scores the quantity of interest (e.g. dose) in 
the user defined region. The scored quantity is always embedded with statistical 
uncertainties. However, the uncertainty can be improved by increasing the number 
of primary particles in the simulation. In other words, by increasing the number of 
incident primary particles, the statistics of radiation interactions can be improved. 
FLUKA has built in capacity to score a great number of quantities of interest e.g. 
particle fluences, current, LET, track length, energy spectra, Z spectra, energy 
deposition, dose, dose equivalent, etc.  
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For the determination of dose equivalent from neutrons, FLUKA employs neutron 
cross sections divided into 260 energy groups (Ferrari et al., 1997) where the lowest 
energy group is 10-5 eV. The wide energy range of neutron cross sections available in 
FLUKA was the primary reason for using FLUKA over other available Monte Carlo 
radiation transport codes. FLUKA is considered a reputable Monte Carlo radiation 
transport code for neutron studies in proton radiotherapy (Moskvin et al., 2012, 
Schneider et al., 2002, Pe´rez-Andu´jar et al., 2012).  
 
In this study, for all particles except neutrons, the transport and secondary electron 
threshold was set to 100 keV. This implies that all the particles except neutrons will 
be transported when the energy is equal to or greater than 100 keV. The particle 
transport and secondary electron could be decreased to 1 keV, but such a low 
energy threshold would significantly increase the computation time. A separate 
routine was compiled to score the dose equivalent from neutrons of energy 1 to 
20 MeV, because the interaction cross section for water with neutrons of energy 
greater than 20 MeV is fairly small. The statistical uncertainty was improved by 
increasing the number of primaries so that the dose equivalent at each location was 
calculated to within a statistical uncertainty of 5%.  
 
 Simulation of simplified snout 4.2
 
A simplified snout which is in use at ProCure Proton Therapy Center, Oklahoma City, 
OK, was modeled using the FLUKA geometry package. The major components of the 
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snout which was simulated in this study were the snout base (brass), snout wall 
(stainless steel), and patient specific aperture (brass). Cross sectional and FLUKA 
geometry diagrams of the snout geometry are shown in Figure 4.2.  
 
 
 
Figure 4.2: The cross sectional diagram of the snout (top), FLUKA geometry generated 
diagram of the snout (bottom). The snout is used at ProCure Proton Treatment Center, 
Oklahoma City, OK (Figure is not in scale).   
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The reason for using the simplified snout is that the major contributions of 
secondary neutrons to the patient come from the patient aperture which is housed 
in the snout, since it is closer to the patient than most other components in beam 
delivery system. A recent study has shown that patient specific aperture in proton 
radiotherapy contributes about 80% to 90% of the total secondary neutrons that 
may reach the patient (Brenner et al., 2009). This study only looks at neutrons 
produced in the snout and inside the phantom.   
 
 Simulation setup 4.3
 
FLUKA simulations were carried out for three proton beams of 78 MeV, 162 MeV, 
and 226 MeV. A common set of treatment parameters was used throughout the 
entire study: a 4 cm spread out Bragg peak (SOBP), a 5 cm diameter patient brass 
aperture, a 10 cm from surface to isocenter, a 28 cm distance from snout to surface 
of the phantom, a 18 x 18 cm2 uncollimated beam, and no range compensator. A 
diagram of the setup is shown in Figure 4.3. As shown in the figure, a polyethylene 
phantom of 0.96 gm/cm3 density was placed in front of the snout to represent a 
patient. The phantom was built by assembling polyethylene blocks, each having a 
dimension of 20 x 20 x 5 cm3. Using these blocks, a phantom of 60 cm in length and 
20 cm in width was created for the experiment. As shown in Figure 4.3, three 
columns of polyethylene blocks were assembled to construct the phantom along the beam 
direction, where the thickness of the phantom differed along the length. The thickness 
of the first and the third column was 35 cm, and the thickness of the second column was 
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52 cm to cover the 135° angled detectors. The detectors were located at 7.5 cm, 17.5 
cm, 28 cm and 35 cm from the beam isocenter at 45°, 90°, and 135° from primary 
beam axis.  
 
 
 
Figure 4.3: Diagram of the setup with the presence of phantom. Dotted circles represent the 
detectors locations where dose equivalent was calculated inside the phantom.     
 
The dimension of each simulated detector was chosen to be 4 x 4 x 0.05 cm3 to 
simulate the experiment that was performed with CR-39 plastic nuclear track 
detectors (PNTDs) of the same dimensions at ProCure Proton Therapy Center, 
Oklahoma City, OK. Water has been chosen as the material of the detector because, 
like water, CR-39 PNTD has a tissue-like sensitivity to neutron. The dimension of the 
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detector, their placement inside the phantom, the shape of the phantom, and the 
treatment parameter mimic exactly the experimental design.     
 
The same experimental configuration was used, except the phantom, for the study of 
neutrons in air. The schematic diagram of detectors location in air is shown in 
Figure 4.4.  
 
 
 
Figure 4.4: Diagram of the experimental setup in air. Circles represent the detectors 
locations.     
 
The study with the presence and absence of phantom will allow us to understand 
the neutron sources and their respective contributions to the total absorbed dose 
and dose equivalent.  
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 Beam Interaction with snout and Phantom  4.4
 
To reproduce the common treatment setup, an uncollimated beam of 18 x 18 cm2 
cross sectional area is created. The field size of the beam is produced by 
determining appropriate divergence of the beam such that a point source of protons 
will uniformly diverge to 20 x 20 cm2 after travelling through 2 m in air. This beam 
is then allowed to pass through the simplified snout and the phantom used in this 
study. A FLUKA simulated 3D view of the interaction of the primary protons with 
snout and the phantom is shown in Figure 4.5. This plot demonstrates how the 
protons start from a point source far upstream and diverge on their way to the 
snout. The patient aperture in the snout shapes the beam to a 5 cm diameter before 
it hits the phantom. The interaction of the beam with snout creates the secondaries 
(blue lines) that scatter in all directions. This plot was created simulating a very low 
number of primary protons (103) for 162 MeV proton beam. The FLUKA simulations 
carried out to determine absorbed dose and dose equivalent consisted of a much 
larger number (~108) primary protons. 
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Figure 4.5: FLUKA simulated 3D view of a 162 MeV proton beam interacting with the snout 
and phantom.  
 
A 2D view of the beam interaction with the snout and phantom is shown in 
Figure 4.6. This plot is also generated for a low number of primaries (103) in order 
to illustrate the primary beam path and the generation of secondary particles 
(mostly neutrons) by the primary proton beam. It can be seen from Figure 4.6 that 
the secondaries are scattered in all directions similar to what was seen in Figure 4.5. 
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Figure 4.6: FLUKA simulated 2D view of 162 MeV primary beam interaction with snout and 
the phantom.    
 
 SOBP Calculation  4.5
 
For the calculation of SOBP, the effect of each layer of the range modulator needs to 
be simulated by running an individual primary beam of specific energy. A weighting 
factor, wi, is assigned for each layer and the dose for the SOBP was calculated by 
performing a weighted sum:  
     ∑  
 
        4.1 
The subscript, i, represents the number of the beam used in the process to produce 
the SOBP. The distal peak (highest energy) carries the highest weight and the 
proximal peak (lowest energy) carries lowest weight. 
Normalized dose 
Particles 
/(cm2.primary) 
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The dose equivalent is then found by:  
 
 
 
 ∑
(
 
 )
(
 
 )
 
 
 4.2 
The H term represents the dose equivalent per unit primary proton and the D term 
represents the respective dose per primary.  
 
Appropriate weighting factors are important for the calculation of SOBP width as 
well as accurate dose deposition. A calculation of a 4 cm SOBP for 226 MeV proton 
beam is explained in this section. The first step was to determine the distal and 
proximal edge of the desired SOBP. For 226 MeV proton beam, the distal edge is 32 
cm in water and to cover a 4 cm SOBP depth, the proximal edge needs to be at 28 
cm, corresponding to a 208.5 MeV proton beam. Two more energies, 219 MeV and 
213 MeV were used in between the distal and proximal edge for the overall 
uniformity of dose. Each beam was then run for the individual Bragg-peak. The dose 
at each Bragg-peak was then used to produce the SOBP by doing a weighted sum 
following Equation 4.1. The Bragg-peak of each individual beam and the weighted 
SOBP for 226 MeV protons is shown in Figure 4.7.  
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Figure 4.7: Bragg-peak of individual primary proton beam and the calculated SOBP for the 
maximum energy of 226 MeV.  
 
The generated SOBP of 78 MeV, 162 MeV and 226 MeV proton beam is shown in 
Figure 4.8.  
 
Distance (cm) 
Normalized dose 
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Figure 4.8: The generated SOBP for 78 MeV, 126 MeV and 226 MeV proton beam. 
  
Figure 4.8 shows that the dose uniformity in the SOBP region is better for 226 MeV 
proton beams compared to 162 MeV and 78 MeV. This is because the width of 
Bragg-peak is inherently greater for 226 MeV protons than the other two beams, 
162 MeV and 78 MeV, and this makes the SOBP region more uniform. The relatively 
larger width of the Bragg-peak for higher energy occurs due to the range strangling 
effect. In order to make a more uniform SOBP dose region for 162 MeV and 78 MeV 
protons, a large number of beams could be used. However, this is not practical in 
actual treatment situation.  
 
 
Distance (cm) 
Normalized dose 
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CHAPTER 5 
 
5 RESULTS 
 
 
This chapter presents the off-axis dose equivalent from secondary neutrons at 
different locations in the presence and absence of a phantom as calculated by 
FLUKA. The dose equivalent is normalized to proton absorbed dose and is shown as 
the ratio of dose equivalent to absorbed proton dose (Hn/Dp). The dependence of off 
axis dose equivalent as functions of distance, energy, and angle is described. The 
fluence of secondary neutrons at different locations is also presented. 
     
 Neutron dose equivalent inside the phantom and in air  5.1
 
Table 5.1 lists the FLUKA calculated dose equivalent due to secondary neutrons at 
different locations inside the phantom and in air for a 78 MeV proton beam. In air, 
the detector locations were nearly identical to those inside the phantom, except at 
90 where the detectors were placed at larger distances from isocenter (40 and 50 
cm). The distance is measured off-axis to the primary beam from beam isocenter.  
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Table 5.1: FLUKA simulated ratios of neutron dose equivalent to proton absorbed dose 
(Hn/Dp) for a 78 MeV primary proton beam at detector locations inside the phantom and in 
air. All the distance is measured from beam isocenter.  
Proton 
Beam 
(MeV) 
Angle 
 
Distance 
In 
phantom 
(cm) 
Hn/Dp 
(mSv/Gy) 
 
Distance 
in  
air (cm) 
Hn/Dp 
(mSv/Gy) 
Phantom Air 
 
 
 
78 
 
45° 
 
 
 
7.5 
 
1.51 ± 0.02 7.50 2.71 ± 0.12 
17.5 0.43 ± 0.01 16.3 
 
2.11 ± 0.07 
28.5 0.21 ± 0.01 28.5 1.52 ± 0.08 
35.5 0.11 ± 0.01 35.0 1.21 ± 0.06 
 
90° 
 
 
 
7.5 
 
1.91 ± 0.02 12.5 3.41 ± 0.17 
17.5 0.52 ± 0.02 18.2 2.82 ± 0.12 
28.5 0.23 ± 0.01 40.0 2.23 ± 0.11 
35.5 0.13 ± 0.01 50.0 1.91 ± 0.07 
 
135° 
 
7.5 3.81 ± 0.02 9.3 4.31 ± 0.21 
18.2 1.41 ± 0.02 17.2 5.03 ± 0.26 
25.5 1.02 ± 0.02 29.5 5.12 ± 0.27 
35.5 1.43 ± 0.01 33 4.71 ± 0.23 
 
 
Figure 5.1 shows the neutron dose equivalent per proton absorbed dose (Hn/Dp) for 
78 MeV proton beam inside the phantom. Inside the phantom, Hn/Dp ranged from 
0.11 ± 0.01 to 3.81 ± 0.02 mSv/Gy, and in air it ranged from 1.21 ± 0.06 to 
5.12 ± 0.27 mSv/Gy for 78 MeV proton beam. In general, Hn/Dp decreases with 
distance at all angles (45, 90, and 135). The exception is increase of Hn/Dp 
observed at large distance (35.5 cm) at 135. Most of the secondary neutrons are 
created by the patient aperture in the snout. At detector locations further away from 
the isocenter (see Figure 4.2 for detector locations), the neutron fluence decreases.  
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Figure 5.1: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 78 MeV proton beam inside the phantom at increasing distances from 
isocenter at 45, 90 and 135 to the direction of the beam.  
 
The fluence spectrum for a 78 MeV proton beam inside the phantom at 90 for 
7.5 cm, 17.5 cm, 28.5 cm, and 35.5 cm is shown Figure 5.2. The fluence spectrum is 
normalized by the total fluence at each location.  The figure possesses two main 
peaks; the first peak is located at about 1 MeV and the second peak is located at 
about 30 MeV (barely visible). The peak at 1 MeV is due to low energy neutrons 
produced by evaporation process, while the peak near 30 MeV corresponds to high 
energy forward moving neutrons due to intranuclear cascades. The neutron fluence 
for energies ranging from 1 to 20 MeV (neutrons energy range used for scoring dose 
equivalent) shows that at 7.5 cm, the average fluence is higher compared to the 
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other distances (17.5 cm, 28.5 cm, 35.5 cm). At 90, as the distance inside the 
phantom increases, neutrons need to travel a relatively longer path, which causes 
more neutron attenuation inside the phantom, resulting in a decrease in fluence. 
Since dose equivalent is related to the fluence, the decrease in neutron fluence 
results in a decrease of the Hn/Dp. 
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Figure 5.2: FLUKA simulated neutron spectrum from a 78 MeV proton beam inside phantom 
at 90 and 7.5 cm, 17.5 cm, 28.5 cm, and 35.5 cm from isocenter 
 
The reason behind the increase in Hn/Dp at the larger distance (35.5 cm) at 135 
inside the phantom is: a) at 135, the detector was closer to the snout which caused 
a higher neutron fluence, and b) at 35.5 cm, the detector was closer to the front 
surface of the phantom, causing the neutrons not to be attenuated as much as they 
 67 
 
would have at greater depths in the phantom. A similar trend of higher Hn/Dp near 
the front surface of the phantom was also observed at 135 compared to other 
angles by Shin et al. (Shin et al., 2009) for single and double scattering beam 
delivery systems. 
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Figure 5.3: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 78 MeV proton beam in air at increasing distances from isocenter at 45, 
90 and 135 to the direction of the beam. 
 
Figure 5.3 shows the plot of Hn/Dp for a 78 MeV proton beam in air. A general 
decreasing trend in Hn/Dp with distance is again visible in air except at 135°, where 
Hn/Dp increases with distance. Overall, higher values of Hn/Dp can be seen in air 
versus inside the phantom at all angles as shown in Figure 5.4. This difference is due 
to the fact that more neutrons are stopped inside the phantom which is much 
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denser than air. This work is in agreement with the study carried by Zhang et. al. 
(Zhang et al., 2010).  
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Figure 5.4: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 78 MeV proton beams inside phantom and air at increasing distances from 
isocenter at 45, 90 and 135 to the direction of the beam. 
 
To help explain the increase in Hn/Dp in air with distances at 135, secondary 
neutron fluence spectrum from 78 MeV at each location is calculated at 135 and is 
shown in Figure 5.5. This plot is shown for the energy range of 1 to 20 MeV. At 
smaller distance (9.3 cm), the fluence is lower while at larger distance (33 cm), the 
fluence is higher. This is because at larger distances from isocenter (33 cm), the 
neutron spectra contain more isotropic neutrons from evaporation processes than 
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forward moving neutrons. Due to these reasons, an increase in dose equivalent in 
air is observed at 135 as the distance increased from isocenter.    
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Figure 5.5. FLUKA simulated neutron spectrum for neutron energy of 1 to 20 MeV 
from a 78 MeV proton beam in air at 135 and 9.3 cm, 17.2 cm, 29.5 cm, and 33 cm 
from isocenter.  
 
Table 5.2 lists the Hn/Dp value calculated by FLUKA for a 162 MeV proton beam 
inside the phantom and in air. Inside the phantom, Hn/Dp ranged from 1.01 ± 0.06 to 
19.31 ± 0.24 mSv/Gy, and in air it ranged from 9.91 ± 0.34 to 39.31 ± 0.71 mSv/Gy.  
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Table 5.2: FLUKA simulated ratios of neutron dose equivalent to proton absorbed 
dose (Hn/Dp) for a 162 MeV primary proton beam at detector locations inside the 
phantom and in air. All the distance is measured from beam isocenter. 
Proton 
Beam 
(MeV) 
 
Angle 
 
Distance 
in 
phantom 
(cm) 
Hn/Dp 
(mSv/Gy) 
Distance 
in Air 
(cm) 
Hn/Dp 
(mSv/Gy) 
 Phantom 
 
Air 
 
 
 
 
162 
 
45° 
 
 
 
7.5 14.12 ± 0.67 7.5 21.51 ± 0.49 
17.5 5.41 ± 0.35 16.3 16.01 ± 0.38 
28.5 2.01 ± 0.21 28.5 11.72 ± 0.35 
35.5 1.01 ± 0.06 35 9.91 ± 0.34 
 
90° 
 
 
 
7.5 16.61 ± 0.66 12.5 26.01 ± 0.52 
17.5 4.71 ± 0.24 18.5 21.02 ± 0.42 
28.5 2.12 ± 0.07 40 17.02 ± 0.47 
35.5 1.40 ± 0.07 50 14.01 ± 0.42 
 
135° 
 
7.5 19.31 ± 0.24 7.5 33.21 ± 0.53 
18.2 13.32 ± 0.65 16.3 39.31 ± 0.71 
25.5 10.21 ± 0.20 28.5 39.22 ± 0.78 
33 12.51 ± 0.21 35 36.52 ± 0.73 
 
 
Figure 5.6, Figure 5.7, and Figure 5.8 shows the Hn/Dp as a function of distance from 
isocenter for a 162 MeV proton beam inside the phantom, in air, and in phantom 
versus in air, respectively. The Hn/Dp trend for the 162 MeV proton beam is similar 
to that observed for the 78 MeV proton beam both in the presence of phantom and 
in the absence of a phantom, i.e. air. Also similar to the 78 MeV proton beam, Hn/Dp 
is seen to increase inside the phantom at largest distance (35.5 cm) at 135, and in 
air the increase of Hn/Dp is observed at 135 at nearly all distances.  
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Figure 5.6: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 162 MeV proton beam inside a phantom at increasing distances from 
isocenter at 45, 90 and 135 to the direction of the beam. 
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Figure 5.7: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 162 MeV proton beam in air at increasing distances from isocenter at 45, 
90 and 135 to the direction of the beam. 
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Figure 5.8: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 162 MeV proton beams inside phantom and in air at increasing distances 
from isocenter at 45, 90 and 135 to the direction of the beam. 
 
Table 5.3 lists the Hn/Dp values calculated by FLUKA for a 226 MeV proton beam 
inside a phantom and in air. Inside the phantom, Hn/Dp ranged from 2.51 ± 0.14 to 
69.21 ± 1.11 mSv/Gy, and in air it ranged from 24.81 ± 0.82 to 111.01 ± 
1.99 mSv/Gy. Figure 5.9, Figure 5.10, and Figure 5.11 shows Hn/Dp as a function of 
distance from isocenter for 226 MeV proton beam inside the phantom, in air, and in 
the phantom versus in air, respectively. Again, the Hn/Dp trend for 226 MeV is 
similar to those observed for 78 MeV and 162 MeV proton beams both in the 
presence of a phantom and in air. In addition, an increase in Hn/Dp was seen at 135 
in air and at larger (25.5 and 35.5 cm) distances in the phantom.  
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Table 5.3: FLUKA simulated ratios of neutron dose equivalent to proton absorbed 
dose (Hn/Dp) for a 226 MeV primary proton beam at detector locations inside the 
phantom and in air. All the distance is measured from beam isocenter. 
Proton  
Beam 
(MeV) 
Angle 
(degree) 
Distance 
in 
phantom 
(cm) 
Hn/Dp 
(mSv/Gy) 
Distance 
in Air 
(cm) 
Hn/Dp 
(mSv/Gy) 
Phantom Air 
 
 
 
226 
 
45° 
 
 
 
7.5 28.61 ± 0.86 7.5 54.01 ± 1.25 
17.5 12.11 ± 0.61 16.3 40.31 ± 1.08 
28.5 5.01 ± 0.25 28.5 30.11 ± 0.91 
35.5 2.51 ± 0.14 35 24.81 ± 0.82 
 
90° 
 
 
 
7.5 35.41 ± 0.92 12.5 66.11 ± 1.32 
17.5 11.51 ± 0.52 18.2 57.41 ± 1.32 
28.5 5.52 ± 0.25 40 45.02 ± 1.26 
35.5 4.01 ± 0.19 50 38.31 ± 1.14 
 
135° 
 
7.5 69.21 ± 1.11 9.3 85.31 ± 1.80 
18.2 33.12 ± 0.86 17.2 106.71 ± 1.92 
25.5 38.03 ± 0.82 29.5 111.01 ± 1.99 
33 58.04 ± 0.99 33 101.01 ± 2.32 
 
 
However, in contrast to the 78 MeV and 162 MeV proton beams, the 226 MeV proton 
beam at 135 shows an increase in Hn/Dp at a distance of 25.5 cm from isocenter as 
well as at 35.5 cm (Figure 5.9). This is because in a 226 MeV proton beam, the 
average energy of the neutrons is greater than the average energy of the neutrons 
created in both 78 MeV and 162 MeV proton beams. Due to this increase in average 
energy, the neutrons are less attenuated in the front region of the phantom. In other 
words, when neutron energy is larger, the cross section (interaction probability) of 
the neutrons with the phantom decreases. As a result at 135, Hn/Dp for higher 
energy, neutrons in the phantom start to behave similar to Hn/Dp in air.  
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Figure 5.9: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 226 MeV proton beam inside a phantom at increasing distances from 
isocenter at 45, 90 and 135 to the direction of the beam. 
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Figure 5.10: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 226 MeV proton beam in air at increasing distances from isocenter at 45, 
90 and 135 to the direction of the beam. 226 MeV water
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Figure 5.11: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, for a 226 MeV proton beam inside a phantom and in air at increasing distances 
from isocenter at 45, 90 and 135 to the direction of the beam. 
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 Neutron dose equivalent dependence on energy 5.2
 
To observe the dependence of Hn/Dp with energy, the detector at 17.5 cm from 
isocenter for all three angles is chosen. The schematic representation is shown in 
Figure 5.12. Figure 5.13 shows Hn/Dp as a function of proton energy at 17.5 cm from 
the beam isocenter and at 45, 90, and 135 inside the phantom and in air.  
 
 
Figure 5.12: Diagram of the locations where dose equivalent was calculated at 17.5 cm from 
isocenter inside the phantom (top) and in air (bottom). 
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The general trend of Hn/Dp demonstrates that the energy of the primary beam 
increases the absorbed dose due to neutrons increases. The highest dose is 
observed for 226 MeV protons and the dose progressively goes down for 162 MeV 
and 78 MeV protons, respectively. For example, at 17.5 cm inside the phantom and 
at 90 to the primary beam, the Hn/Dp decreases from 11.51 ± 0.52 mSv/Gy for 226 
MeV protons to 0.52 ± 0.02 mSv/Gy for 78 MeV protons, while in air the Hn/Dp 
decreases from 57.41 ± 1.32 mSv/Gy for 226 MeV protons to 2.82 ± 0.12 mSv/Gy for 
78 MeV protons. This is expected since higher energy protons create more neutrons 
when they undergo nuclear interactions in the nozzle. The effective scan area is also 
an important parameter in neutron production for uniform scanning beam systems, 
since a larger effective area results in greater neutron production.  
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Figure 5.13: FLUKA simulated neutron dose equivalent per therapeutic proton 
absorbed dose, Hn/Dp, at 17.5 cm, 90 to primary beam, for 78 MeV, 162 MeV and 226 
MeV protons inside a phantom (left) and in air (right). 
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 Dependence of dose equivalent on angle 5.3
 
Hn/Dp as a function of measured angle with respect to the beam for a fixed distance of 
17.5 cm for all three proton energies inside the phantom and in air is shown in Figure 
5.14. As the angle increases from 45 to 135, Hn/Dp inside the phantom increases by up 
to a factor of 3.5 at 17.5 cm for 78 MeV protons, 2.4 for 162 MeV protons and 2.7 for 
226 MeV protons. The general trend of dose increase was also observed for each energy, 
though at 90 a decrease in dose equivalent was also observed in phantom as the angle 
increased. It could be that in phantom in the 45 detectors the forward moving neutrons 
(>~10 MeV) make a significant contribution in addition to isotropic neutrons (<10 MeV), 
but that at 90 the contribution from forward moving neutrons becomes less, leading to 
the decrease seen in Hn/Dp.  At 135, the fluence from isotropic neutrons is higher as they 
are closer to the nozzle and this leads to an increase in Hn/Dp. However, in all cases both 
in phantom and in air, Hn/Dp at 135 is higher compared to Hn/Dp values measured at 45 
and 90. 
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Figure 5.14: FLUKA simulated neutron dose equivalent per therapeutic proton absorbed 
dose, Hn/Dp, at 17.5 cm for 78 MeV, 162 MeV, 226 MeV protons inside the phantom (left), 
and in air (right). 
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CHAPTER 6 
 
6 Discussion and Conclusions 
 
 
The primary aim of this study was to determine the dose equivalent due to 
secondary neutrons for three different primary proton energies, 78 MeV, 162 MeV, 
and 226 MeV and a simplified snout configuration used in proton radiotherapy. We 
investigated the detailed spatial distribution of secondary neutron dose equivalent 
to primary proton dose, Hn/Dp, inside a phantom and in air for a fixed aperture size, 
fixed SOBP, and a fixed snout to surface distance using a uniform scanning nozzle at 
ProCure Proton Therapy Center, Oklahoma City, OK. This data can provide useful 
information for the radiation risk modeling from neutron exposure in proton 
radiotherapy. 
 
In general, the ratio of dose equivalent from secondary neutrons calculated outside 
the treatment volume to primary proton dose, Hn/Dp, decreased with distance from 
beam isocenter both inside a phantom and in air. In air, Hn/Dp was observed to be 
higher than in the phantom for identical locations. Inside the phantom Hn/Dp ranged 
from 0.11 ± 0.01 to 3.81 ± 0.02 mSv/Gy for a 78 MeV proton beam, 1.01 ± 0.06 to 
19.31 ± 0.24 mSv/Gy for a 162 MeV proton beam, and 2.51 ± 0.14 to 
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69.21 ± 1.11 mSv/Gy for a 226 MeV proton beam, respectively. In air Hn/Dp values 
ranged from 1.21 ± 0.06 to 4.31 ± 0.21 mSv/Gy for a 78 MeV proton beam, 
9.91 ± 0.34 to 39.31 ± 0.71 mSv/Gy for a 162 MeV proton beam, and 24.81 ± 0.82 to 
111.01 ± 1.99 mSv/Gy for a 226 MeV proton beam, respectively.  
 
Comparison of data from this study with the results from other beam line designs 
and patient specific factors is difficult since the treatment nozzle and beam 
condition vary from facility to facility and neutron dose equivalent varies greatly 
between different beam delivery systems. However, relative comparisons of similar 
setups can be made. A comparison of results for 78 MeV and 162 MeV proton beams 
from this study with different uniform scanning and passive scattering studies is 
shown in     Table 6.1. As shown in the table, results obtained in this study are 
consistent with previously published results (Zheng et al., 2012) for the same 
uniform scanning system.  Zheng et al. reported that the Hn/Dp for 5 cm range 
proton beam, with a 30 × 30 × 30 cm3 phantom centered at isocenter, was 
0.35 mSv/Gy for a 4 cm SOBP, where the detector location was 50 cm lateral to the 
primary axis. In the current study, Hn/Dp for the same beam conditions but 35.5 cm 
lateral to primary beam axis was 0.13 ± 0.01 mSv/Gy. Also shown in the table, Yan et 
al. (Yan et al., 2002) reported 4.5 mSv/Gy for 160 MeV protons at 50 cm, 8.2 cm 
modulation width, and with a phantom at isocenter of 26 cm diameter and 24 cm 
length. At that position in the current study for 162 MeV protons in air, Hn/Dp was 
1.4 mSv/Gy. In a separate study, Polf and Newhauser (Polf and Newhauser, 2005) 
determined from Monte Carlo simulation Hn/Dp for similar experimental conditions 
 82 
 
to those used by Yan et al. (Yan et al., 2002). They found Hn/Dp to be 3.9 mSv/Gy for 
a 160 MeV proton beam, 3 cm modulation width at 900 to the beam axis and 50 cm 
from the isocenter. This comparison indicates that the production of neutrons and 
corresponding values of Hn/Dp for the uniform scanning system is of a similar order 
of magnitude to that produced by a passive scattering system.  
 
    Table 6.1: Comparison of this study with other published work. The Hn/Dp value     
     listed for 78 MeV proton beam of this study was measured at 35 cm from  
     isocenter. The rest of the listed Hn/Dp values were measured at 50 cm from   
     isocenter.   
 
The statistical uncertainty in the FLUKA simulation was around 5%, though the 
fluence to dose equivalent conversion in the simulation could add as much as 30% 
uncertainty to the values of Hn/Dp (Schneider et al., 2002). This study does not 
incorporate the contribution of Hn/Dp from thermal and epithermal neutrons (up to 
an energy of 1 MeV), because the detector we used in experiments was insensitive in 
that energy region. We are currently investigating the contributions from thermal 
and epithermal neutrons for uniform scanning beams. In addition, this study did not 
 
Type 
Proton Beam 
(MeV) 
Hn/Dp           
(mSv/Gy) 
This study (uniform scanning) 
Zheng et al (2012) (uniform scanning) 
 This study (uniform scanning) 
   Polf et.al (2005) (passive scattering) 
Yan et al. (2002) (passive scattering) 
78 
78 
162 
160 
160 
0.1 
0.35 
1.4 
3.9 
4.5 
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include any range compensator which may lead to some differences with actual 
neutron dose equivalent to tissue surrounding the treatment volume in patient 
treatment.  The whole study was conducted only for one particular setup of 
treatment parameters which might be different from an actual treatment scenario. 
 
Currently, an experiment is in progress using the same setup that was used in these 
simulations. CR-39 PNTD is used in the experiments to measure the secondary 
neutron dose equivalent.  
 
Also, in the future, a detailed simulation of beam delivery system for varying patient 
specific parameters, e.g. various beam scanning areas, different snout size, and 
different SOBP can be performed for the better estimation of Hn/Dp. This can help 
understanding the detail distribution of neutron dose in proton radiotherapy.  
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